Syndax Pharmaceuticals Inc — Form D

Syndax Pharmaceuticals Inc of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-28. The offering totals $61.3M, of which $61.3M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Henry W ChenDirectorWaltham, MA
Fabrice Egros, Ph.D.DirectorWaltham, MA
Luke Evnin, Ph.D.DirectorWaltham, MA
Kim Kamdar, Ph.DDirectorWaltham, MA
Briggs W Morrison, M.D.DirectorWaltham, MA
Dennis PodlesakDirectorSAN DIEGO, CA
Ivor Royston, M.D.DirectorWaltham, MA
Richard P SheaDirectorWaltham, MA
George W Sledge, Jr., M.D.DirectorWaltham, MA
Michael W MetzgerExecutive OfficerWaltham, MA
Briggs W Morrison, M.D.Executive OfficerWaltham, MA
John PalliesExecutive OfficerWaltham, MA
Ivor RoystonDirectorLa Jolla, CA
Arlene MorrisDirectorHolytown, Motherwell, X0
Arlene MorrisExecutive OfficerHolytown, Motherwell, X0
Kim Kamdar, Ph.D.DirectorSan Diego, CA
George W Sledge, Jr. M.D.DirectorWaltham, MA
Fabrice EgrosDirectorWaltham, MA
Steven St. Peter, M.D.DirectorWaltham, MA
Joanna Horobin, M.D.DirectorWaltham, MA
Joanna Horobin, M.D.Executive OfficerWaltham, MA
Kim Kamdar, PhDDirectorWaltham, MA
Rosina Maar Pavia, M.D.DirectorWaltham, MA
Robert Goodenow, PhDExecutive OfficerWaltham, MA
Robert Goodenow, Ph.D.Executive OfficerWaltham, MA

Other filings by this issuer (8)

FiledFormOfferingSold
2015-06-15D$45.2M$24.0M
2014-09-19D$5.0M$4.9M
2014-02-13D$1.3M$1.3M
2014-02-13D$1.7M$1.7M
2013-11-14D$50K$50K
2013-08-30D$48.4M$31.3M
2010-08-05D$7.0M$6.0M
2010-02-03D$16.0M$9.0M

More